You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2024

CLINICAL TRIALS PROFILE FOR FERRIC CITRATE

✉ Email this page to a colleague

« Back to Dashboard

505(b)(2) Clinical Trials for Ferric Citrate

This table shows clinical trials for potential 505(b)(2) applications. See the next table for all clinical trials

Subscribe to access the full database, or Sign Up
Trial Type	Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
New Formulation	NCT00967993 ↗	Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease	Completed	Keryx Biopharmaceuticals		2010-01-01	The objective of this study is to see if KRX-0502 (ferric citrate) is safe and effective as a dietary phosphate binder in controlling and managing serum phosphorus levels in patients with end-stage renal disease (ESRD).
>Trial Type	>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

All Clinical Trials for Ferric Citrate

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00648167 ↗	A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD)	Completed	Collaborative Study Group (CSG)	Phase 2	2008-03-01	This study is to evaluates the safety and tolerability of Zerenex™ (ferric citrate) as a treatment for hyperphosphatemia in patients with End-Stage Renal Disease.
NCT00648167 ↗	A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD)	Completed	Keryx Biopharmaceuticals	Phase 2	2008-03-01	This study is to evaluates the safety and tolerability of Zerenex™ (ferric citrate) as a treatment for hyperphosphatemia in patients with End-Stage Renal Disease.
NCT00967993 ↗	Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease	Completed	Keryx Biopharmaceuticals		2010-01-01	The objective of this study is to see if KRX-0502 (ferric citrate) is safe and effective as a dietary phosphate binder in controlling and managing serum phosphorus levels in patients with end-stage renal disease (ESRD).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Ferric Citrate

Condition Name

Chart
Table

Condition Name for Ferric Citrate
Intervention	Trials
Hyperphosphatemia	15
End Stage Renal Disease	11
End-Stage Renal Disease	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Ferric Citrate
Intervention	Trials
Kidney Diseases	21
Renal Insufficiency, Chronic	21
Hyperphosphatemia	16
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Ferric Citrate

Trials by Country

Map
Table

Trials by Country for Ferric Citrate
Location	Trials
United States	159
Puerto Rico	4
Taiwan	3
Israel	3
China	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Ferric Citrate
Location	Trials
Texas	12
California	11
Florida	10
Georgia	8
Ohio	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Ferric Citrate

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Ferric Citrate
Clinical Trial Phase	Trials
Phase 4	6
Phase 3	13
Phase 2/Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Ferric Citrate
Clinical Trial Phase	Trials
Completed	22
Not yet recruiting	5
Recruiting	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Ferric Citrate

Sponsor Name

Chart
Table

Sponsor Name for Ferric Citrate
Sponsor	Trials
Keryx Biopharmaceuticals	15
Rockwell Medical Technologies, Inc.	9
Panion & BF Biotech Inc.	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Ferric Citrate
Sponsor	Trials
Industry	31
Other	12
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.